Ankyrons® – Advanced Research Tools for Investigating Emerging Infectious Diseases

Dr. Fry introduces “Ankyrons,” a novel recombinant protein technology designed as small (15 kDa), high-affinity alternatives to traditional antibodies, addressing challenges like high cost, slow development, and limited tissue penetration. Ankyrons are generated from a highly diverse library via ribosome display, allowing rapid, high-throughput production against specific protein targets, including novel pathogen proteins. They are versatile, compatible with existing assays (e.g., immunofluorescence, flow cytometry, immunohistochemistry), and can be customized for multivalent or multispecific applications. With thousands of clones targeting proteins across hundreds of species, Ankyrons offer a cost-effective and accessible tool for accelerating pathogen research and diagnostics.